Sarepta Therapeutics (SRPT) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.51% |
| Dec 31, 2025 | 45.86% |
| Sep 30, 2025 | 21.11% |
| Jun 30, 2025 | 33.06% |
| Mar 31, 2025 | -23.97% |
| Dec 31, 2024 | 52.36% |
| Sep 30, 2024 | -17.30% |
| Jun 30, 2024 | -20.57% |
| Mar 31, 2024 | -14.91% |
| Dec 31, 2023 | -22.21% |
| Sep 30, 2023 | -9.08% |
| Jun 30, 2023 | 33.07% |
| Mar 31, 2023 | -17.50% |
| Dec 31, 2022 | -31.98% |
| Sep 30, 2022 | -17.61% |
| Jun 30, 2022 | -27.36% |
| Mar 31, 2022 | -50.77% |
| Dec 31, 2021 | 31.26% |
| Sep 30, 2021 | -18.60% |
| Jun 30, 2021 | 23.89% |
| Mar 31, 2021 | 13.23% |
| Dec 31, 2020 | 3.09% |
| Sep 30, 2020 | -64.51% |
| Jun 30, 2020 | -90.92% |
| Mar 31, 2020 | 302.00% |
| Dec 31, 2019 | 38.99% |
| Sep 30, 2019 | -10.64% |
| Jun 30, 2019 | 8.23% |
| Mar 31, 2019 | 30.35% |
| Dec 31, 2018 | 63.43% |
| Sep 30, 2018 | -29.97% |
| Jun 30, 2018 | -65.79% |
| Mar 31, 2018 | -16.55% |
| Dec 31, 2017 | -16.21% |
| Sep 30, 2017 | 101.59% |
| Jun 30, 2017 | -77.24% |
| Mar 31, 2017 | 78.89% |
| Dec 31, 2016 | -111.45% |
| Sep 30, 2016 | 107.18% |
| Jun 30, 2016 | 19.02% |
| Mar 31, 2016 | -32.63% |
| Dec 31, 2015 | 65.18% |
| Sep 30, 2015 | -77.67% |